Nirsevimab - Respiratory Syncytial Virus (RSV) immunisation
You are here : Home > Formulary Search > Nirsevimab - Respiratory Syncytial Virus (RSV) immunisation
I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.
Status 1
Red
Formulations :
- Pre-filled syringe
Formulary Status :
Associated Icons :
NHSE
Restrictions / Comments :
Documentation
- No records returned.
PAD Profile
ChemicalSubstance :
Nirsevimab
Indication :
Respiratory Syncytial Virus (RSV) immunisation
Group Name :
Keywords :
Respiratory Syncytial Virus RSV
Brand Names Include :
Beyfortus
Important Information :
For use in line with 'The Green Book'
Latest Additions Date From :
23 Sep 2025
Latest Additions Date To :
23 Oct 2025
Guidelines :
Supporting Documents :
0
Committee Recommendations (0)
- No records returned.
Other Indications
Below are listed other indications that Nirsevimab is used to treat.
- No records returned.
Other Drugs
Below are listed other drugs that are used to treat Respiratory Syncytial Virus (RSV) immunisation.
- No records returned.